These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8080884)

  • 1. Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: relationship with platelet count.
    van Genderen PJ; Michiels JJ; van der Poel-van de Luytgaarde SC; van Vliet HH
    Ann Hematol; 1994 Aug; 69(2):81-4. PubMed ID: 8080884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential diagnostic and treatment difficulties in a patient with acquired von Willebrand syndrome.
    Magyari F; Kracskó B; Bedekovics J; Bereczky Z; Illés Á; Schlammadinger Á
    Hematology; 2021 Dec; 26(1):301-304. PubMed ID: 33663351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocytapheresis for acquired von Willebrand syndrome in a patient with essential thrombocythemia and recent multivisceral transplantation.
    Oyedeji O; Sheqwara J; Onwubiko I; Lopez-Plaza I; Nagai S; Otrock ZK
    Transfusion; 2021 Nov; 61(11):3277-3280. PubMed ID: 34569071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired von Willebrand disease due to increasing platelet count can readily explain the paradox of thrombosis and bleeding in thrombocythemia.
    Michiels JJ
    Clin Appl Thromb Hemost; 1999 Jul; 5(3):147-51. PubMed ID: 10725999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding complications after arthroscopy in a JAK2V617F-positive patient with essential thrombocythemia and acquired von Willebrand syndrome (AVWS).
    Rupa-Matysek J; Lewandowski K; Lewandowska M; Wojtasińska E; Wojtaszewska ML; Walczak M; Bykowska K; Komarnicki M
    Int J Hematol; 2015 Apr; 101(4):405-10. PubMed ID: 25432436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Successful management of intraperitoneal bleeding with platelet apheresis and von Willebrand factor supplementation in a patient with essential thrombocythemia and acquired von Willebrand syndrome].
    Ueki T; Takeshige K; Sumi M; Ueno M; Ichikawa N; Kobayashi H
    Rinsho Ketsueki; 2017; 58(8):922-926. PubMed ID: 28883275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding signs due to acquired von Willebrand syndrome at diagnosis of chronic myeloid leukaemia in children.
    Knöfler R; Lange BS; Paul F; Tiebel O; Suttorp M
    Br J Haematol; 2020 Mar; 188(5):701-706. PubMed ID: 31617211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The paradox of bleeding and thrombosis in thrombocythemia: is von Willebrand factor the link?
    van Genderen PJ; Leenknegt H; Michiels JJ
    Semin Thromb Hemost; 1997; 23(4):385-9. PubMed ID: 9263356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report: Peri-procedural hydroxyurea helps minimize bleeding in patients with Essential Thrombocythemia associated with acquired von Willebrand syndrome.
    Kogan L; Price R; Kotchetkov R
    Front Oncol; 2024; 14():1326209. PubMed ID: 38361779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
    Shihong I; Morris D; Konkle BA
    Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls.
    Quiroga T; Goycoolea M; Panes O; Aranda E; Martínez C; Belmont S; Muñoz B; Zúñiga P; Pereira J; Mezzano D
    Haematologica; 2007 Mar; 92(3):357-65. PubMed ID: 17339185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excessive prolongation of the bleeding time by aspirin in essential thrombocythemia is related to a decrease of large von Willebrand factor multimers in plasma.
    van Genderen PJ; van Vliet HH; Prins FJ; van de Moesdijk D; van Strik R; Zijlstra FJ; Budde U; Michiels JJ
    Ann Hematol; 1997; 75(5-6):215-20. PubMed ID: 9433378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired von Willebrand disease in myeloproliferative disorders.
    van Genderen PJ; Leenknegt H; Michiels JJ; Budde U
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():79-82. PubMed ID: 8951776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reduction of large von Willebrand factor multimers in plasma in essential thrombocythaemia is related to the platelet count.
    van Genderen PJ; Budde U; Michiels JJ; van Strik R; van Vliet HH
    Br J Haematol; 1996 Jun; 93(4):962-5. PubMed ID: 8703834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclical thrombocytosis, acquired von Willebrand syndrome and aggressive non-melanoma skin cancers are common in patients with Philadelphia-negative myeloproliferative neoplasms treated with hydroxyurea.
    Verner E; Forsyth C; Grigg A
    Leuk Lymphoma; 2014 May; 55(5):1139-43. PubMed ID: 23879199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulminant Essential Thrombocythemia Associated with Acquired Von Willebrand Syndrome and Bleeding Episodes in a 14-year-old Girl.
    Schneider C; Stutz-Grunder E; Lüer S; Keller P; Kremer Hovinga JA; Ammann RA; Karow A
    Hamostaseologie; 2019 Nov; 39(4):404-408. PubMed ID: 30895567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of multimer organization of von Willebrand factor in an acquired von Willebrand syndrome.
    Casonato A; Pontara E; Doria A; Bertomoro A; Cattini MG; Gambari PF; Girolami A
    Br J Haematol; 2002 Mar; 116(4):899-904. PubMed ID: 11886398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
    Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
    Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased clearance of von Willebrand factor in a patient with type 2B von Willebrand disease following development of immune thrombocytopenia.
    Wang ZJ; Onwuzurike N; Callaghan MU; Rajpurkar M; Chitlur M; Lusher JM
    Pediatr Blood Cancer; 2008 Sep; 51(3):416-8. PubMed ID: 18493997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors related to the development of acquired von Willebrand syndrome in patients with essential thrombocythemia and polycythemia vera.
    Rottenstreich A; Kleinstern G; Krichevsky S; Varon D; Lavie D; Kalish Y
    Eur J Intern Med; 2017 Jun; 41():49-54. PubMed ID: 27919526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.